Alexa Richardson Health Law Policy Opioid Crisis Personhood Pregnancy Scientific Evidence Student Fellows Opioid Claims for Fetal Opioid Exposure Alarm Pregnancy Advocates Read more: Opioid Claims for Fetal Opioid Exposure Alarm Pregnancy Advocates
Generic Drugs Pharmaceuticals Phebe Hong Legal Challenges to California’s Pay-for-Delay Ban Read more: Legal Challenges to California’s Pay-for-Delay Ban
Health Law Policy The Ethical Conundrums of Ultra-personalized Drugs Read more: The Ethical Conundrums of Ultra-personalized Drugs
2020 Election Affordable Care Act David Orentlicher Health Care Reform Health Law Policy Sustaining the Promise of Universal Access Read more: Sustaining the Promise of Universal Access
Health Care Reform Health Law Policy Public Health Lost in the Jungle of Patient Safety Reports, Publications and Initiatives? Read more: Lost in the Jungle of Patient Safety Reports, Publications and Initiatives?
Addiction Daniel Aaron Health Law Policy Opioid Crisis Pharmaceuticals Public Health Social Determinants of Health Supreme Court Ohio’s Efforts to Centralize Control Over Opioid Claims Read more: Ohio’s Efforts to Centralize Control Over Opioid Claims
Abortion Beatrice Brown Bioethics Student Fellows Supreme Court Challenging the Contours of the “Undue Burden” Standard in June Medical Services v. Gee: A Slippery Slope? Read more: Challenging the Contours of the “Undue Burden” Standard in June Medical Services v. Gee: A Slippery Slope?
Generic Drugs Health Law Policy Pharmaceuticals Phebe Hong Stopping the Pharmaceutical “Product Hop” Read more: Stopping the Pharmaceutical “Product Hop”
Health Law Policy Intellectual Property Research Funding Novartis, Dana Farber, Oregon Health & Science University Wait 18 Years to Disclose NIH Funding in Key Gleevec Patent Read more: Novartis, Dana Farber, Oregon Health & Science University Wait 18 Years to Disclose NIH Funding in Key Gleevec Patent
Bioethics Biotechnology Conflicts of Interest Doctor-Patient Relationship Health Law Policy Genetic Testing: Is There a “Duty to Warn” At-Risk Family Members? Read more: Genetic Testing: Is There a “Duty to Warn” At-Risk Family Members?